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INTRODUCTION:  Invasive  lobular  carcinoma  is  the  second  most  common  type  of invasive  breast  carcinoma
(between  5%  and  15%).  The  incidence  of  invasive  lobular  carcinoma  has  been  increasing  while the inci-
dence  of invasive  duct  carcinoma  has  not  changed  in the  last  two  decades.  This  increase  is  postulated  to
be secondary  to an  increased  use of  combined  replacement  hormonal  therapy.  Patients  with  invasive lob-
ular  carcinoma  tend  to  be slightly  older  than  those  with  non-lobular  invasive  carcinoma  with  a  reported
mean  age  of  57  years  compared  to 64  years.  On  mammography,  architectural  distortion  is more  common
and  microcalciﬁcations  less  common  with  invasive  lobular  carcinoma  than  invasive  ductal  carcinoma.
The  incidence  of  extrahepatic  gastrointestinal  (GI)  tract metastases  observed  in  autopsy  studies  varies
in the  literature  from  6%  to  18%  with  the  most  commonly  affected  organ  being  the  stomach,  followed
by  colon  and rectum.  Gastric  lesions  seem  to be slightly  more  frequent,  compared  to colorectal  lesions
(6–18%  compared  to  8–12%,  respectively).
PRESENTATION  OF  CASE:  We  present  the  case  of  a 70-year-old  woman  who  was  referred  to  our  institu-
tion with  a  concurrent  gastric  and  rectal cancer  that on  further  evaluation  was  diagnosed  as metastatic
invasive  lobular  carcinoma  of  the  breast.  She  has  a stage  IV  clinical  T3N1M1  left breast  invasive  lobular
carcinoma  (ER positive  at 250,  PR  negative,  HER-2/neu  1+ negative)  with  biopsy  proven  metastases  to left
axillary lymph  nodes,  gastric  mucosa,  peritoneum,  rectal  mass,  and  bone  who  presented  with a  partial
large bowel  obstruction.  She is  currently  being  treated  with  weekly  intravenous  paclitaxel,  bevacizumab
that  was  added  after  her  third  cycle,  and  she  is  also  receiving  monthly  zoledronic  acid.  She  is  currently
undergoing  her  12-month  of  treatment  and  is  tolerating  it well.
Discussion Breast  cancer  is the  most  common  site-speciﬁc  cancer  in  women  and  is  the  leading  cause
of  death  from  cancer  for women  aged  20–59  years.  It accounts  for  26%  of all newly  diagnosed  cancers  in
females  and  is  responsible  for  15%  of  the  cancer-related  deaths  in women.9 Breast  cancer  is  one  of  the
most  common  malignancies  that  metastasize  to the  GI tract, along  with  melanoma,  ovarian  and  bladder
cancer.
CONCLUSION:  We  present  one  of the  ﬁrst  reports  of metastatic  lobular  breast  cancer  presenting  as a
synchronous  rectal  and  gastric  tumors.  Metastatic  lobular  carcinoma  of  the  breast is a  rare  entity  with
a  wide  range  of  clinical  presentations.  A  high  level  of suspicion,  repetition  of endoscopic  procedures,
and  a detailed  pathological  analysis  is  necessary  for early  diagnosis,  which  might  help  to  avoid  sur-
gical  treatment  due  to  incorrect  diagnosis.  Patients  with  a history  of breast  cancer  who  present  with
new  gastrointestinal  lesions  should  have  these  lesions  evaluated  for evidence  of  metastasis  through
histopathologic  evaluation  and  immunohistochemical  analysis.  Differentiating  between  a  primary  GI
lesion and  metastatic  breast  cancer  will  allow  initiation  of  appropriate  treatment  and  help  prevent
unnecessary  operations.
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. IntroductionInvasive lobular carcinoma is the second most common type
f invasive breast cancer. In most series, these tumors account for
pproximately 5–10% of invasive breast carcinomas. The reported
∗ Corresponding author at: 333 Cottman Avenue, Philadelphia, PA 19111, United
tates. Tel.: +1 215 728 3095; fax: +1 215 728 2773.
E-mail address: rodrigo.arrangoiz@yahoo.com (R. Arrangoiz).
210-2612 © 2011 Surgical Associates Ltd. Published by Elsevier Ltd.  
oi:10.1016/j.ijscr.2011.06.010
Open access under CCssociates Ltd. Published by Elsevier Ltd. 
incidence of this tumor type has ranged, between 1% and 20%.1,2
Most of these differences are related to diagnostic criteria as well
as the variability in patient populations.2 The incidence of inva-
sive lobular carcinoma has been increasing while the incidence of
invasive duct carcinoma has not changed in the last two  decades.
This increase is postulated to be secondary to an increased use
Open access under CC BY-NC-ND license.of combined hormonal replacement therapy.3 Patients with inva-
sive lobular carcinoma tend to be slightly older than those with
non-lobular invasive carcinoma, with a reported mean age of 57
years compared to 64 years.1 Invasive lobular carcinomas are
 BY-NC-ND license.
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nig. 1. CT scan of the abdomen and pelvis showing the nearly obstructing rectal
ass.
haracterized by multifocality in the ipsilateral breast and appear
o be more often bilateral than other types of invasive breast can-
er, although the reported range of bilaterality has been broad
6–46%).3,4 On mammography, architectural distortion is more
ommon and microcalciﬁcations less common with invasive lob-
lar carcinoma than invasive ductal carcinoma. At the time of
iagnosis, 60% of patients will have lymph node or distant organ
etastases, and about 30–80% of patients will develop metastatic
isease following surgery and/or chemotherapy, radiotherapy, or
ndocrine therapy.4
Lobular carcinoma tends to spread to bones, gynecologi-
al organs, peritoneum and retroperitoneum, and is less likely
o involve the gastrointestinal tract (GI).5–7 The incidence of
xtrahepatic gastrointestinal (GI) tract metastases observed in
utopsy studies varies in the literature from 6% to 18% with
he most commonly affected organ being the stomach, followed
y colon and rectum. Gastric lesions seem to be slightly more
ig. 2. CT scan of the chest showing a right upper lobe nodule and left axillary lymph
ode.
Fig. 3. Gastric mucosa thickeningPEN  ACCESS
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frequent, compared to colorectal lesions (6–18% compared to
8–12%, respectively).8
We  present the case of a 70-year-old woman who was referred
to our institution with a concurrent gastric and rectal cancer that
on further evaluation was diagnosed as metastatic invasive lobular
carcinoma of the breast.
2. Presentation of case
This is a 70-year-old woman with a 3-month history of
decreased stool caliber, alternating episodes of diarrhea and con-
stipation, and increased ﬂatulence. Two  months previously she
had a fall from standing height that required her to take codeine.
This led to constipation and abdominal pain. She then presented
to a local emergency department for persistent abdominal pain
where a CT scan of the abdomen and pelvis was performed and
interpreted as negative. She subsequently underwent diagnostic
colonoscopy demonstrating a circumferential obstructing rectal
mass that required the use of a pediatric colonoscope to advance
beyond the lesion. The lesion measured 4 cm in length, starting at
3 cm from the anal verge to approximately 7 cm proximally, mul-
tiple biopsies where taken. She also underwent upper endoscopy
demonstrating an area of mucosal thickening which was  biopsied.
She had continued intermittent abdominal pain, colicky in nature
associated with diarrhea. She lost approximately 10 pounds in a
month.
The pathology report from the rectal and gastric biopsies
showed non-speciﬁc inﬂammation and poorly differentiated inva-
sive carcinoma which was  noted to be ER/PR positive. A repeat CT
scan of the abdomen and pelvis revealed circumferential thicken-
ing of the rectum. It extended from the junction of the rectum and
sigmoid colon towards the anus with two  liver lesions 2 mm and
5 mm in size (Fig. 1). On physical examination she was found to
have a palpable mass in the left upper outer quadrant of the breast,
as well as a left axillary mass.
Upon further questioning she revealed that approximately 1
year before the onset of her gastrointestinal symptoms she had
felt a breast mass, but had never brought it to anyone’s attention. A
month prior to the onset of her gastrointestinal symptoms she had
her annual bilateral screening mammogram that revealed no suspi-
cious masses or lesions. A CT of the chest revealed multiple enlarged
left axillary lymph nodes, no mediastinal adenopathy, and a solitary
pulmonary nodule in the right upper lobe measuring 6 mm (Fig. 2).
Repeat EGD (Fig. 3) and colonoscopy (Fig. 4) with biopsies were
done which revealed lobular carcinoma consistent with a breast
primary. An ultrasound guided biopsy of the axillary lymph node
was performed revealing metastatic invasive lobular carcinoma.
She underwent bilateral breast MRI  and this again revealed left
axillary adenopathy, the largest 3.1 cm × 2.1 cm (Fig. 5). In the pos-
terior lateral central left breast there was a 7.4 cm × 1.8 cm × 6.6 cm
area of irregular heterogeneous enhancement. Due to persistent
 and erosion in the fundus.
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for CEA and BRST-2. They were negative for CK20 and CDX-2
(Figs. 8 and 9). The needle core biopsy of the rectum, the multiple
biopsies of the peritoneum and falciform ligament also demon-
strated metastatic lobular carcinoma from breast (Fig. 10).Fig. 4. Rectal mass at approx
bdominal pain consistent with a partial large bowel obstruction,
he underwent exploratory laparotomy with peritoneal nodule
iopsy and diverting colostomy. She also underwent rectal mass
ore biopsy, as well as left breast core biopsy. All of the areas biop-
ied revealed invasive lobular carcinoma consistent with a breast
rimary. They were ER positive, PR negative, HER-2/neu 1+ nega-
ive.
In summary this 70-year-old woman had a stage IV clinical
3N1M1 left breast invasive lobular carcinoma (ER positive at 250,
R negative, HER-2/neu 1+ negative) with biopsy proven metas-
ases to left axillary lymph nodes, gastric mucosa, peritoneum,
ectal mass, and bone who presented with a partial large bowel
bstruction. She is currently being treated with weekly intravenous
aclitaxel, bevacizumab that was added after her third cycle, and
he is also receiving monthly zoledronic acid. She is currently
ndergoing her 12-month of treatment and is tolerating it well.
he has a grade I neuropathy and grade II nail changes which is not
nterfering with her activities of daily living. Our plan at this point
s to continue on her current treatment protocol for one additional
ycle and then restage her with a CT scan of the chest, abdomen
nd pelvis, and bone scan. We  did discuss the possibility of tak-
ng a break from the paclitaxel if things continue to look good and
ince she is having painful nail changes. She is ER positive and we
ould potentially consider antiestrogen therapy at some point in
he future.
.1. PathologyThe left breast and axillary lymph node ultrasound guided core
iopsy demonstrated metastatic lobular carcinoma. Immunohis-
ochemistry performed with good positive and negative controls
evealed tumor cells staining strongly positive for ER (250) and
ig. 5. MRI  of the breasts showing an abnormality of the left upper outer quadrant.ly 5 cm from the anal verge.
focally positive for CEA and BRST-2. They were negative for CK20,
CDX-2 and PR (Figs. 6 and 7).
The biopsies obtained from the greater curvature of the stom-
ach and duodenum showed metastatic lobular carcinoma from the
breast. Immunohistochemistry performed on the specimen with
good positive and negative controls revealed tumor cells staining
strongly positive for ER (250) and PR (200) and focally positiveFig. 6. Core needle biopsy of breast mass.
Fig. 7. Core needle biopsy of breast mass.
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Fig. 8. Gastric and duo




iFig. 10. Core biopsy of the rectum.
. DiscussionBreast cancer is the most common site-speciﬁc cancer in women
nd is the leading cause of death from cancer for women aged
0–59 years. It accounts for 26% of all newly diagnosed cancers
n females and is responsible for 15% of the cancer-related deathsdenal biopsies.
in women.9 Breast cancer is one of the most common malignan-
cies that metastasize to the GI tract, along with melanoma, ovarian
and bladder cancer.10 Breast cancer rarely metastasizes to the colon
or rectum, more commonly metastasizing to the stomach or small
bowel. There tends to be a histological preference for the site of
distant metastasis, invasive ductal carcinoma of the breast has a
tendency to metastasize more commonly to the liver, lung, and
brain compared to lobular carcinoma that tends to spread to bones,
gynecological organs, peritoneum, retroperitoneum, and the gas-
trointestinal tract.11,12 The reason for this has not been identiﬁed.
An interesting aspect of our case is the involvement not only of
the rectum but also of the stomach and peritoneum synchronously.
Gastric metastases from mammary carcinomas frequently develop
many years after the primary tumor, raising suspicions about a
new primary cancer within the stomach. In our case the tumors
were synchronous with the primary breast cancer. The time interval
between primary breast cancer and gastrointestinal involvement
may  range from synchronous presentation to as long as 30 years but
reverse is also true, with the GI manifestation preceding a diagnosis
of breast cancer.13–15 Invasive lobular carcinoma of the breast that
metastasizes to the stomach may occur as discrete lesions (nod-
ules, erosions, and/or ulcerations) or as linitis plastica with diffuse
inﬁltration of the submucosa and muscularis propria.
The clinical manifestations that metastatic breast cancer to
the GI tract can have are variable. Symptoms may  range from
non-speciﬁc complaints to acute GI symptoms. The diagnosis of
metastatic lesions to the GI tract becomes even more unlikely on the
rare occasion when it represents the ﬁrst manifestation of breast
cancer.16 In our case the patient presented initially with GI symp-
toms that made her seek medical attention without taking into
account the breast lesion that she had noticed previously.
Histologic diagnosis of metastatic lesions can be difﬁcult. The
lack of dysplasia or atypia of the rectal epithelium and the glands
surrounding the malignant cells is often helpful in distinguishing
between a primary and a metastatic lesion, but immunohisto-
chemistry will allow for the most accurate diagnosis. Markers that
help conﬁrm the diagnosis are gross cystic disease ﬂuid protein-
15 (GCDFP-15), estrogen (ER) and progesterone (PR) receptors. The
GCDFP-15 and the ER and/or PR are positive in metastatic lesions
of the breast, in contrast to most colorectal or gastric carcino-
mas, which are usually negative. One report showed that primary
gastric carcinomas can express the ER in approximately 20–28%
of the time.17 The signet-ring morphology of lobular carcinoma
may  mimic  gastric carcinoma. Some authors suggest that given the
high incidence of breast cancer and the low incidence of diffuse-
type gastric cancer in the USA, we should consider the presence of
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etastatic lobular carcinoma of the breast in every woman  diag-
osed with diffuse-type gastric cancer.13
Systemic treatment with chemotherapy, endocrine therapy or a
ombination of both is usually started in patients with breast can-
er that metastasize to the GI tract. Remissions are observed in
2–53% of patients.18 Survival after diagnosis of GI metastases from
 breast primary is poor with few patients surviving beyond two
ears, although survival up to nine years has been reported.19,20
. Conclusion
We present one of the ﬁrst reports of metastatic lobular breast
ancer presenting as a synchronous rectal and gastric tumors.
etastatic lobular carcinoma of the breast is a rare entity with
 wide range of clinical presentations. A high level of suspicion,
epetition of endoscopic procedures, and a detailed pathologi-
al analysis is necessary for early diagnosis, which might help to
void surgical treatment due to incorrect diagnosis. Patients with
 history of breast cancer who present with new gastrointesti-
al lesions should have these lesions evaluated for evidence of
etastasis through histopathologic evaluation and immunohisto-
hemical analysis. Differentiating between a primary GI lesion and
etastatic breast cancer will allow initiation of appropriate treat-
ent and help prevent unnecessary operations.
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